Corixa Corporation (Nasdaq:CRXA) today announced that its stockholders have adopted the merger agreement pursuant to which Corixa will be merged...
Corixa Corporation (Nasdaq:CRXA) today announced preliminary results of its first clinical trial of CRX-675, a toll-like receptor 4 (TLR4...
Corixa Corporation (Nasdaq:CRXA), a developer of immunotherapeutics, today announced financial results for the first quarter ended March 31...
Corixa Corp. (Nasdaq:CRXA), a developer of immunotherapeutics, will hold a live conference call and webcast to discuss the company's first quarter...
GlaxoSmithKline to Acquire Corixa Corporation - Developer of Novel Vaccine Adjuvants and Antigens LONDON and PHILADELPHIA, April 29...
Gen-Probe Licenses from Corixa Rights to Develop Molecular Diagnostic Tests for Potential Markers of Genitourinary and Other Cancers - Agreement...
GlaxoSmithKline and Corixa Sign on as National Sponsors of The Leukemia & Lymphoma Society's Light The Night Walk WHITE PLAINS, N.Y., Sept. 21...
Corixa and GlaxoSmithKline Announce Results of Two Studies of BEXXAR(R) Following Chemotherapy as First-Line Treatment of Non-Hodgkin's Lymphoma...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.